We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Meritage Homes
MTH
$4.86B
| $84K | ﹤0.01% |
2,050
-5,796
| -74% | -$274K |
|
1077
Zumiez
ZUMZ
$339M
| $84K | ﹤0.01% |
2,285
+47
| +2% | +$1.58K |
|
1078
Avient
AVNT
$4.19B
| $83K | ﹤0.01% |
2,061
| – | – |
|
1079
MACOM Technology Solutions
MTSI
$23.7B
| $83K | ﹤0.01% |
+1,526
| New | +$65.1K |
|
|
SGMO
1080
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $83K | ﹤0.01% |
+5,347
| New | +$62.6K |
|
1081
Boise Cascade
BCC
$3.02B
| $82K | ﹤0.01% |
1,732
+51
| +3% | +$2.21K |
|
1082
Allient
ALNT
$1.92B
| $81K | ﹤0.01% |
2,382
| – | – |
|
1083
SIGA Technologies
SIGA
$219M
| $81K | ﹤0.01% |
+11,159
| New | +$78.6K |
|
1084
Alnylam Pharmaceuticals
ALNY
$29.3B
| $80K | ﹤0.01% |
616
+18
| +3% | +$2.4K |
|
1085
IDT Corp
IDT
$1.62B
| $80K | ﹤0.01% |
+6,481
| New | +$71.8K |
|
1086
Insteel Industries
IIIN
$625M
| $80K | ﹤0.01% |
3,614
+56
| +2% | +$1.27K |
|
1087
Stewart Information Services
STC
$2.08B
| $80K | ﹤0.01% |
1,665
| – | – |
|
1088
Regenxbio
RGNX
$708M
| $79K | ﹤0.01% |
1,759
+356
| +25% | +$12.4K |
|
1089
Verastem
VSTM
$592M
| $79K | ﹤0.01% |
+3,112
| New | +$62.5K |
|
|
ABMD
1090
DELISTED
Abiomed Inc
ABMD
| $79K | ﹤0.01% |
+244
| New | +$67.5K |
|
|
PFPT
1091
DELISTED
Proofpoint, Inc.
PFPT
| $79K | ﹤0.01% |
582
| – | – |
|
1092
Agilysys
AGYS
$3.06B
| $78K | ﹤0.01% |
2,035
-350
| -15% | -$11.6K |
|
1093
Amkor Technology
AMKR
$13.7B
| $78K | ﹤0.01% |
5,199
-1,630
| -24% | -$22.2K |
|
1094
Danaos Corp
DAC
$2.56B
| $78K | ﹤0.01% |
+3,641
| New | +$46.8K |
|
1095
IES Holdings
IESC
$15.2B
| $78K | ﹤0.01% |
1,714
-683
| -28% | -$26.7K |
|
1096
Nexstar Media Group
NXST
$5.92B
| $78K | ﹤0.01% |
722
+358
| +98% | +$34.9K |
|
1097
Ribbon Communications
RBBN
$383M
| $78K | ﹤0.01% |
+11,966
| New | +$63.2K |
|
1098
Inspire Medical Systems
INSP
$1.74B
| $77K | ﹤0.01% |
+414
| New | +$67.7K |
|
1099
SFL Corp
SFL
$1.61B
| $77K | ﹤0.01% |
+12,272
| New | +$85K |
|
1100
Super Micro Computer
SMCI
$20.1B
| $77K | ﹤0.01% |
24,510
+20,240
| +474% | +$57.1K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.